Automate Your Wheel Strategy on XOMAP
With Tiblio's Option Bot, you can configure your own wheel strategy including XOMAP - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol XOMAP
- Rev/Share 3.585
- Book/Share 7.0707
- PB 3.6291
- Debt/Equity 1.3524
- CurrentRatio 5.541
- ROIC -0.0446
- MktCap 307071851.0
- FreeCF/Share -0.5034
- PFCF -50.9663
- PE -107.4242
- Debt/Assets 0.538
- DivYield 0.084
- ROE -0.0325
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
About XOMA Corporation (XOMAP)
- IPO Date 2020-12-16
- Website https://www.xoma.com
- Industry Biotechnology
- CEO Owen P. Hughes Jr.
- Employees 13
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.